群馬大学神経科学グループ 脳研究統合フォーラム
  • 文字サイズ
  • 小
  • 中
  • 大
アクセス・お問合せ

業績集

サブメニューを開く

医学系研究科・高次機能統御系

脳神経内科学分野

  1. Hayashi S, Amari M, and Okamoto K:
    Loss of calretinin- and parvalbumin-immunoreactive axons in anterolateral columns beyond the corticospinal tracts of amyotrophic lateral sclerosis spinal cords.
    J Neurol Sci., 331: 61-66, 2013. (IF: 2.243)
  2. Sakurai A, Makioka K, Fukuda T, Takatama M, and Okamoto K.
    Accumulation of phosphorylated TDP-43 in the CNS of a patient with Cockayne syndrome.
    Neuropathology., 33: 673-677, 2013. (IF: 1.909)
  3. Furuta N, Makioka K, Fujita Y, Ikeda M, Takatama M, Matsuoka M, and Okamoto K.
    Reduced expression of BTBD10 in anterior horn cells with Golgi fragmentation and pTDP-43-positive inclusions in patients with sporadic amyotrophic lateral sclerosis.
    Neuropathology., 33: 397-404, 2013. (IF: 1.909)
  4. Liu W, Yamashita T, Tian F, Morimoto N, Ikeda Y, Deguchi K, and Abe K.
    Mitochondrial fusion and fission proteins expression dynamically change in a murine model of amyotrophic lateral sclerosis.
    Curr Neurovasc Res., 10: 222-230, 2013. (IF: 2.844)
  5. Miyazaki K, Yamashita T, Morimoto N, Sato K, Mimoto T, Kurata T, Ikeda Y, and Abe K.
    Early and selective reduction of NOP56 (Asidan) and RNA processing proteins in the motor neuron of ALS model mice.
    Neurol Res., 35: 744-754, 2013. (IF: 1.182)
  6. Kurata T, Miyazaki K, Morimoto N, Kawai H, Ohta Y, Ikeda Y, and Abe K.
    Atorvastatin and pitavastatin reduce oxidative stress and improve IR/LDL-R signals in Alzheimer’s disease.
    Neurol Res., 35: 193-205, 2013. (IF: 1.182)
  7. Sato K, Morimoto N, Kurata T, Mimoto T, Miyazaki K, Ikeda Y, and Abe K.
    Impaired hypoxic sensor Siah-1, PHD3, and FIH system in spinal motor neurons of an amyotrophic lateral sclerosis mouse model.
    J Neurosci Res., 91: 285-291, 2013. (IF: 2.974)
  8. Furuta N, Makioka K, Fujita Y, and Okamoto K.
    Changes in the clinical features of amyotrophic lateral sclerosis in rural Japan.
    Intern Med., 52: 1691-1696, 2013. (IF: 0.973)
  9. Ikeda M, Yonemura K, Kakuda S, Tashiro Y, Fujita Y, Takai E, Hashimoto Y, Makioka K, Furuta N, Ishiguro K, Maruki R, Yoshida J, Miyaguchi O, Tsukie T, Kuwano R, Yamazaki T, Yamaguchi H, Amari M, Takatama M, Harigaya Y, and Okamoto K.
    Cerebrospinal fluid levels of phosphorylated tau and Aβ1-38/Aβ1-40/Aβ1-42 in Alzheimer’s disease with PS1 mutations.
    Amyloid., 20: 107-112, 2013. (IF: 4.436)
  10. Sohmiya M, Wada N, Tazawa M, Okamoto K, and Shirakura K.
    Immediate effects of physical therapy on gait disturbance and frontal assessment battery in Parkinson’s disease.
    Geriatr Gerontol Int., 13: 630-637, 2013. (IF: 2.167)
  11. Matsuzono K, Yoshiki T, Wakutani Y, Manabe Y, Yamashita T, Deguchi K, Ikeda Y, and Abe K.
    Synchronized Babinski and Chaddock signs preceded the MRI findings in a case of repetitive transient ischemic attack.
    Intern Med., 52: 2127-2129, 2013. (IF: 0.973)
  12. Matsuzono K, Ikeda Y, Deguchi S, Yamashita T, Kurata T, Deguchi K, and Abe K.
    Cerebral embolic stroke after disappearing takotsubo cardiomyopathy.
    J Stroke Cerebrovasc Dis., 22: e682-683, 2013. (IF: 1.984)
  13. Matsuzono K, Kurata T, Deguchi S, Yamashita T, Deguchi K, Ikeda Y, and Abe K.
    Two Unique Cases with Anti-GluR Antibody-Positive Encephalitis.
    Clin Med Insights Case Rep., 23: 113-117, 2013. (IF:無し)
  14. Matsuzono K, Ikeda Y, Liu W, Kurata T, Deguchi S, Deguchi K, and Abe K.
    A novel familial prion disease causing pan-autonomic-sensory neuropathy and cognitive impairment.
    Eur J Neurol., 20: e67-69, 2013. (IF: 4.162)
  15. Kono S, Deguchi K, Morimoto N, Kurata T, Yamashita T, Ikeda Y, Narai H, Manabe Y, Takao Y, Kawada S, Kashihara K, Takehisa Y, Inoue S, Kiriyama H, and Abe K.
    Intravenous thrombolysis with neuroprotective therapy by edaravone for ischemic stroke patients older than 80 years of age.
    J Stroke Cerebrovasc Dis., 22: 1175-1183, 2013. (IF: 1.984)
  16. Deguchi K, Kono S, Deguchi S, Morimoto N, Kurata T, Ikeda Y, and Abe K.
    A novel useful tool of computerized touch panel-type screening test for evaluating cognitive function of chronic ischemic stroke patients.
    J Stroke Cerebrovasc Dis., 22: e197-206, 2013. (IF: 1.984)
  17. Morimoto N, Yamashita T, Sato K, Kurata T, Ikeda Y, Kusuhara T, Murata N, and Abe K.
    Assessment of swallowing in motor neuron disease and Asidan/SCA36 patients with new methods.
    J Neurol Sci., 324: 149-155, 2013. (IF: 2.243)
  18. Ikeda Y, Ohta Y, Kurata T, Shiro Y, Takao Y, and Abe K.
    Acoustic impairment is a distinguishable clinical feature of Asidan/SCA36.
    J Neurol Sci., 324: 109-112, 2013. (IF: 2.243)

PAGETOP